Euglobulin Lysis Time

The euglobulin lysis test is a global screen of your body’s fibrinolysis, the process that breaks down blood clots. In this test, proteins from your plasma that drive or regulate fibrinolysis are separated into a fraction called the euglobulin fraction. A small clot is formed from this fraction in the lab and the time it takes to dissolve is observed.

Because it uses only selected plasma proteins, the test is influenced mainly by the activators and inhibitors of plasmin, while many clotting factors have less impact. This makes it a simple way to look for unusually strong or weak fibrinolytic activity.

Your clinician may order this test when there is unexplained bleeding, concern for excessive clot breakdown after surgery or childbirth, liver disease, or possible effects of medicines that change fibrinolysis. It can also be used as an overall check of clot breakdown in certain specialized settings.

Results can suggest increased fibrinolysis, which may contribute to easy bruising or bleeding, or reduced fibrinolysis, which can contribute to ongoing clot formation. The test is usually interpreted together with other hemostasis tests such as fibrinogen, D-dimer, prothrombin time, activated partial thromboplastin time, and sometimes viscoelastic testing.

If the clot dissolves more quickly than expected, it suggests heightened fibrinolytic activity. If it takes longer than expected, it suggests reduced fibrinolytic activity. Because the method is sensitive to how the sample is collected and handled, results are often confirmed with a repeat test or with more specific assays.

Depending on the pattern, your clinician may order related tests that look at clotting and fibrinolysis more directly, such as fibrinogen, D-dimer, tissue plasminogen activator, plasminogen, plasmin inhibitor, or viscoelastic tests. Treatment focuses on the underlying cause. If medicines are involved, dosing or drug choice may be adjusted. If bleeding risk is high, antifibrinolytic therapy may be considered, while other situations may call for watchful follow-up without immediate treatment.